ESC Professional Premium Access

Coronary artery disease - Treatment

Event: ESC Congress 2022
Topic: Treatment
Session type: Moderated ePosters
Date: 26 August 2022
Time: 13:15 - 13:55

Congress Session

5 presentations in this session

Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial

Speaker: Doctor R. Pracon (Warsaw, PL)

Impact of high intensity interval training on coronary atheromatous plaques evaluated by IVUS - a randomized trial

Speaker: Mrs E. Vesterbekkmo (Trondheim, NO)

Effect of supervised high-intensity interval training on haemostasis in patients with coronary artery disease: a randomised controlled trial

Speaker: Doctor J. Kristiansen (Torshavn, FO)

Coronary sinus reducer device for the treatment of refractory angina therapy. A multicentric initial experience.

Speaker: Doctor C. Brizido (Carnaxide, PT)

Immunomodulatory effect of first-in-human PeriCord cardiac bioimplant: preliminary data of the PERISCOPE clinical trial

Speaker: Doctor M. Monguio-Tortajada (Badalona, ES)

5 speakers from this session

Doctor Radoslaw Pracon

National Institute of Cardiology, Warsaw (Poland)
1 presentation
0 follower

Mrs Elisabeth K Vesterbekkmo

Norwegian University of Science and Technology, Trondheim (Norway)
1 follower

Doctor Jacobina Kristiansen

National Hospital of the Faroe Islands, Torshavn (Faroe Islands)
0 follower

Doctor Catarina Brizido

Hospital de Santa Cruz, Carnaxide (Portugal)
0 follower

Doctor Marta Monguio-Tortajada

Health Science Research Institute Germans Trias i Pujol, Badalona (Spain)
0 follower

This platform is supported by

logo Novo Nordisk